The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shaposhnikova E.V.

Maternity Home №4, Clinico-diagnostic Department, Krasnoyarsk, Russia

Kozhukhar' V.V.

Krasnoiarskiĭ gosudarstvennyĭ meditsinskiĭ universitet

Methods of Contraception in hiv-positive women

Authors:

Shaposhnikova E.V., Kozhukhar' V.V.

More about the authors

Read: 10089 times


To cite this article:

Shaposhnikova EV, Kozhukhar' VV. Methods of Contraception in hiv-positive women. Russian Journal of Human Reproduction. 2012;(3):30‑33. (In Russ.)

References:

  1. Ivanova E.V. i dr. Vnutrimatochnaya gormonal'naya sistema: voprosy priemlemosti i bezopasnosti. Akush i gin 2011; 4: 140-144.
  2. Gevorkyan M.A., Manukhin I.B., Yurkovets M.G. Gormonal'naya kontratseptsiya: konsul'tirovanie v vybore metodov i rezhimov predokhraneniya ot nezhelatel'noi beremennosti. Vopr ginekol akush i perinatol 2011; 10: 1: 83-86.
  3. Lineva O.I., Glukhova M.V. Vliyanie vnutrimatochnoi levonorgestrelsoderzhashchei rilizing-sistemy Mirena na metabolicheskie parametry u zhenshchin s gormonozavisimoi patologiei matki i povyshennoi massoi tela. Ginekologiya 2007; 9: 5: 227.
  4. Manukhin I.B., Tumilovich L.G., Gevorkyan M.A. Klinicheskie lektsii po ginekologicheskoi endokrinologii. M: GEOTAR-Media 2009.
  5. Meditsinskie kriterii priemlemosti metodov kontratseptsii. Pod red. G.T. Sukhikh. Zdorov'e sem'i 2011;1:18.
  6. Ponomareva M.V. i dr. Novye vozmozhnosti obespecheniya kontratseptsii VICh-infitsirovannykh zhenshchin. Trudnyi patsient 2006; 9: 4: 48-49.
  7. Prilepskaya V.N., Bostandzhyan L.L. Lechebnye aspekty ispol'zovaniya vnutrimatochnoi levonorgestrel rilizing-sistemy (obzor literatury). Ginekologiya 2009; 9: 2: 4-9.
  8. Reproduktivnoe zdorov'e VICh-infitsirovannykh zhenshchin. Rukovodstvo po okazaniyu kompleksnoi meditsinskoi pomoshchi zhenshchinam s VICh. Pod red. N.V. Vartapetovoi, A.V. Karpushkinoi. M: IZS 2008; 111.
  9. Tikhomirov A.L. Dolgovremennyi vysokoeffektivnyi obratimyi kontratseptiv s lechebnymi svoistvami. Rus med zhurn 2007; 15: 17: 1-4.
  10. Department of Health and Human Services, Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use. Adapted from World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition. 2010. http://www.cdc.gov/reproductive_ health/UnintendedPregnan­cy/USMEC.htm.
  11. Faculty of Family Planning and Reproductive Health Care, Royal College of Obstetricians and Gynecologist. UK Medical Eligibility Criteria for Contraceptive Use. London 2009.
  12. Hannaford P.C. The progestogen content of combined oral contraceptives and venous thromboembolic risk. BMJ 2011; 343: d6592. doi: 10.1136/bmj.d6592.
  13. Turrentine J.E. Clinical Protocols Obstetrics Gynecology. Informa 2008; 448.
  14. Verchaeghe J. Hormonal contraception in women with metabolic syndrome. Contraception Reproductive Health Care 2010; 5: 5: 305-314.
  15. World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 4th edition. Geneva: WHO 2009. http://www.who.int/reproductive_health/publications/mec/family_planning/9789241563888/en/index.html.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.